Join Medimaps Group during the 2022 ISCD Annual Meeting on Thursday March 31st 1.20pm – 2.00pm ET for a panel discussion on Integrating Trabecular Bone Score (TBS) into Clinical Practice with Dr. Michael Lewiecki and Dr. Andrea Singer, two world-renowned leaders in the field of osteoporosis, and bone and mineral disease.
The panel will share their years of experience and insights on the use of TBS in clinical practice and will cover the following:
- Understanding the clinical benefits of TBS
- How to use TBS in combination with BMD and FRAX in clinical practice
- How TBS can help fine-tune treatment decisions
- Learn about the reimbursement for TBS
The discussion will be followed by a 10-minute Q&A session.
Developed by Medimaps Group, TBS Osteo is an FDA and CE mark approved solution which is considered gold standard in bone micro-architecture assessment. It computes a Trabecular Bone Score™ (TBS), which provides useful clinical information on microarchitectural deterioration of bone tissue, thereby improving the accuracy of osteoporosis identification. Moreover, TBS has now 4 new dedicated CPT codes for US reimbursement. For more information, click here.